Compare A & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | A | CNC |
|---|---|---|
| Founded | 1999 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.0B | 33.5B |
| IPO Year | 1999 | 2001 |
| Metric | A | CNC |
|---|---|---|
| Price | $138.60 | $63.17 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 16 |
| Target Price | ★ $161.47 | $46.75 |
| AVG Volume (30 Days) | 1.9M | ★ 2.9M |
| Earning Date | 05-27-2026 | 04-28-2026 |
| Dividend Yield | ★ 0.92% | N/A |
| EPS Growth | ★ 3.16 | N/A |
| EPS | 2.27 | ★ 3.11 |
| Revenue | $4,472,000,000.00 | ★ $194,777,000,000.00 |
| Revenue This Year | $8.45 | $8.31 |
| Revenue Next Year | $6.13 | $1.05 |
| P/E Ratio | $61.56 | ★ $20.49 |
| Revenue Growth | 6.43 | ★ 19.44 |
| 52 Week Low | $108.35 | $25.08 |
| 52 Week High | $160.27 | $69.36 |
| Indicator | A | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 60.89 | 45.55 |
| Support Level | $135.68 | $63.20 |
| Resistance Level | $138.62 | $69.32 |
| Average True Range (ATR) | 3.81 | 2.23 |
| MACD | 0.26 | -0.67 |
| Stochastic Oscillator | 79.70 | 6.77 |
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.